





Foundayo™ (orforglipron) is FDA-approved for chronic weight management. It’s in the same class of medication as injectable GLP-1s with no needle required, ever. If prescribed, it'll ship straight to your door after a quick online visit with a licensed provider.

*In the ATTAIN-1 Phase 3 clinical trial, participants taking the highest dose of Foundayo® who completed 72 weeks of treatment lost an average of 12.4% of their body weight (27.3 pounds), compared to 0.9% with placebo, when combined with a reduced-calorie diet and increased physical activity. Source: Foundayo Prescribing Information. Lilly USA, LLC, 2026.













Foundayo® pricing starts at $149/month for new patients using cash pay. Price does not include the $125 Shed membership and provider fee, paid directly to Shed. Medication costs are paid separately to the dispensing pharmacy.
Foundayo® (orforglipron) is FDA-approved for chronic weight management in adults with obesity or overweight with at least one weight-related condition. Results vary by individual and are not guaranteed. Weight loss depends on factors such as diet, exercise, adherence, medical history, and individual response.
Providers may evaluate patients and prescribe Foundayo® when clinically appropriate. Prescriptions are based on a medical evaluation and are at the provider's discretion.
Shed is not a pharmacy and does not dispense medications. Prescriptions are fulfilled and shipped by a third-party dispensing pharmacy. Medications carry risks and side effects [hyperlink to SE page]. Patients should review the full Prescribing Information and Medication Guide and discuss risks with their provider.
Foundayo® may cause tumors in the thyroid, including thyroid cancer. Do not use if you or any family member has had medullary thyroid carcinoma (MTC), or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Common side effects include nausea, constipation, diarrhea, vomiting, indigestion, stomach pain, headache, and fatigue. Foundayo may reduce the effectiveness of oral birth control pills, and providers may recommend alternative contraception for 30 days after starting and after each dose increase. This is not a complete list of side effects. See full Prescribing Information at foundayo.lilly.com.
Foundayo® is a registered trademark of Eli Lilly and Company. Shed is not affiliated with or endorsed by Eli Lilly and Company.
*Weight loss results based on ATTAIN-1 Phase 3 clinical trial data for participants taking the highest dose who completed 72 weeks of treatment with a reduced-calorie diet and increased physical activity. Source: Foundayo Prescribing Information. Lilly USA, LLC, 2026.
Weight-loss solutions designed to transform and sustain
Longevity medications designed to extend and enhance